Q&A With Sibyl E. Wray, MD, From Hope Neurology Multiple Sclerosis Center: Survey Shows Patients Want More Involvement in MS Treatment

Video

A recent study conducted of patients with multiple sclerosis showed that a change could be coming in the field. Just as patients said they wanted to be more involved in their choice of treatment options, their healthcare professionals said they encouraged feedback from the patients.

A recent study conducted of patients with multiple sclerosis showed that a change could be coming in the field. Just as patients said they wanted to be more involved in their choice of treatment options, their healthcare professionals said they encouraged feedback from the patients.

Sibyl E. Wray, MD, From Hope Neurology Multiple Sclerosis Center discussed the results of the survey and what it could mean to treatment of the condition in the future during the American Academy of Neurology's annual meeting in Washington DC. The survey consisted of more than 900 patients and more than 900 doctors. Wray said more than 97% of doctors believe patients should be more involved in the decision making process. "They're more invested in their care when they help make the decision," she said.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.